Active immunotherapy in malignant melanoma.
D001500:BCG Vaccine / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008545:Melanoma / Q000401:mortality / Q000628:therapy*
D001500:BCG Vaccine